BWS Financial Inc

BWS provides independent stock specific research focused on companies with distinct value that are going through a special situation where there is a tangible catalyst not priced in. The catalyst can be anything from new product, restructuring, M&A, management change, change in business strategy, etc. BWS’s focus is to understand the change and evaluate the potential return for investors.

BWS utilizes a self formed proprietary approach in discovering stocks by putting great emphasis on deep research. BWS does generate short recommendations following a similar criteria.

Independent Stock Specific Research

ASRT: Convertible Offering Pauses Momentum

Founder, BWS Financial Inc

Hamed Khorsand

Founder

Equity Bottom-Up

<ul>
<li>ASRT is classic roll-up story where it is leveraging cash flow from one drug to create a portfolio of multiple drugs</li>
<li>ASRT has managed to stay under investor radars through acquisitions of drugs with small revenue streams. The revenue is starting to add up </li>
<li>ASRT can use its digital marketing approach to grow earnings and free cash flow from each of the drugs it acquires</li>
</ul>


ASRT is classic roll-up story where it is leveraging cash flow from one drug to create a portfolio of multiple drugs
ASRT has managed to stay under investor radars through acquisitions of drugs with small revenue streams. The revenue is starting to add up 
ASRT can use its digital marketing approach to grow earnings and free cash flow from each of the drugs it acquires


Assertio Holdings

ASRT: Rolling Up with Buy Initiation